Sign In
Stocks
News
ETFs
Economy
Currencies
Press Releases
Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH
Published 8 months ago
via
GlobeNewswire